Cargando…

ABO blood groups as a prognostic factor for recurrence in ovarian and vulvar cancer

The relationship between ABO blood groups (BG) and risk of incidence in cancers including gynecological cancers has been widely studied, showing increased incidence risk for BG A patients. As available data are inconsistent we investigated whether BG and their anti-glycan antibodies (anti-A and anti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Montavon Sartorius, Céline, Schoetzau, Andreas, Kettelhack, Henriette, Fink, Daniel, Hacker, Neville F., Fedier, André, Jacob, Francis, Heinzelmann-Schwarz, Viola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5875852/ https://www.ncbi.nlm.nih.gov/pubmed/29596526 http://dx.doi.org/10.1371/journal.pone.0195213

Ejemplares similares

Outcome in serous ovarian cancer is not associated with LATS expression
por: Montavon, Céline, et al.
Publicado: (2019)

Blood Plasma-Derived Anti-Glycan Antibodies to Sialylated and Sulfated Glycans Identify Ovarian Cancer Patients
por: Pochechueva, Tatiana, et al.
Publicado: (2016)

Diaphragmatic smears are not of additional benefit in the detection of peritoneal spread in gynecological cancers
por: Montavon, Celine, et al.
Publicado: (2018)

Impact of the new FIGO 2013 classification on prognosis of stage I epithelial ovarian cancers
por: Sartorius, Céline Montavon, et al.
Publicado: (2018)

Fibrin-thrombin sealant does not reduce lymphocele formation in patients with inguinofemoral lymphadenectomy for vulvar cancer
por: Saner, Flurina AM, et al.
Publicado: (2019)

A clinicopathological review of 33 patients with vulvar melanoma identifies c-KIT as a prognostic marker
por: HEINZELMANN-SCHWARZ, VIOLA A., et al.
Publicado: (2014)

Expression of GBGT1 is epigenetically regulated by DNA methylation in ovarian cancer cells
por: Jacob, Francis, et al.
Publicado: (2014)

Careful Selection of Reference Genes Is Required for Reliable Performance of RT-qPCR in Human Normal and Cancer Cell Lines
por: Jacob, Francis, et al.
Publicado: (2013)

Reliable in vitro studies require appropriate ovarian cancer cell lines
por: Jacob, Francis, et al.
Publicado: (2014)

Tumor-Associated Glycans and Their Role in Gynecological Cancers: Accelerating Translational Research by Novel High-Throughput Approaches
por: Pochechueva, Tatiana, et al.
Publicado: (2012)

An interdisciplinary team-training protocol for robotic gynecologic surgery improves operating time and costs: analysis of a 4-year experience in a university hospital setting
por: Vigo, Francesco, et al.
Publicado: (2021)

Exposure to escalating olaparib does not induce acquired resistance to PARPi and to other chemotherapeutic compounds in ovarian cancer cell lines
por: Fedier, André, et al.
Publicado: (2022)

Tissue glycomics distinguish tumour sites in women with advanced serous adenocarcinoma
por: Anugraham, Merrina, et al.
Publicado: (2017)

Epigenetic activation of MGAT3 and corresponding bisecting GlcNAc shortens the survival of cancer patients
por: Kohler, Reto S., et al.
Publicado: (2016)

Targeting the ROR1 and ROR2 receptors in epithelial ovarian cancer inhibits cell migration and invasion
por: Henry, Claire, et al.
Publicado: (2015)

High‐grade serous peritoneal cancer follows a high stromal response signature and shows worse outcome than ovarian cancer
por: Jacob, Francis, et al.
Publicado: (2020)

Hormone Receptor Expression in Primary and Recurrent High-Grade Serous Ovarian Cancer and Its Implications in Early Maintenance Treatment
por: Vetter, Marcus, et al.
Publicado: (2022)

Should MMMT still be treated with adjuvant taxane-based combination chemotherapy?
por: Heinzelmann-Schwarz, Viola, et al.
Publicado: (2020)

Overlapping gene dependencies for PARP inhibitors and carboplatin response identified by functional CRISPR-Cas9 screening in ovarian cancer
por: Coelho, Ricardo, et al.
Publicado: (2022)

Naturally occurring anti-glycan antibodies binding to Globo H-expressing cells identify ovarian cancer patients
por: Pochechueva, Tatiana, et al.
Publicado: (2017)

Expression pattern of class I histone deacetylases in vulvar intraepithelial neoplasia and vulvar cancer: a tissue microarray study
por: Samartzis, Nicolas, et al.
Publicado: (2011)

L1CAM is not a reliable predictor for lymph node metastases in endometrial cancer, but L1CAM positive patients benefit from radiotherapy
por: Zeiter, Deborah, et al.
Publicado: (2021)

Loss of Secreted Frizzled-Related Protein 4 Correlates with an Aggressive Phenotype and Predicts Poor Outcome in Ovarian Cancer Patients
por: Jacob, Francis, et al.
Publicado: (2012)

Perioperative management with ferric carboxymaltose and tranexamic acid to reduce transfusion rate in gynaecological carcinoma surgery (TRANAFER-Study): study protocol for a single-blind, monocentre, randomised trial
por: Amstad, Gabriela, et al.
Publicado: (2022)

Comparison of printed glycan array, suspension array and ELISA in the detection of human anti-glycan antibodies
por: Pochechueva, Tatiana, et al.
Publicado: (2011)

The glycosphingolipid P(1) is an ovarian cancer-associated carbohydrate antigen involved in migration
por: Jacob, F, et al.
Publicado: (2014)

Meta-Analysis of Microarray Data Identifies GAS6 Expression as an Independent Predictor of Poor Survival in Ovarian Cancer
por: Buehler, Michelle, et al.
Publicado: (2013)

The Prognostic Role of the Surgical Margins in Squamous Vulvar Cancer: A Retrospective Australian Study
por: Barlow, Ellen L., et al.
Publicado: (2020)

Outcome of vulvar reconstruction in patients with advanced and recurrent vulvar malignancies
por: Zhang, Wei, et al.
Publicado: (2015)

Medial Inguino-Femoral Lymphadenectomy for Vulvar Cancer: An Approach to Decrease Lymphedema without Compromising Survival
por: Hacker, Neville F., et al.
Publicado: (2021)

A forgotten disease: Pelvic congestion syndrome as a cause of chronic lower abdominal pain
por: Jurga-Karwacka, Agnieszka, et al.
Publicado: (2019)

Patient-derived and artificial ascites have minor effects on MeT-5A mesothelial cells and do not facilitate ovarian cancer cell adhesion
por: Estermann, Manuela, et al.
Publicado: (2020)

Nivolumab in chemotherapy-resistant cervical cancer: report of a vulvitis as a novel immune-related adverse event and molecular analysis of a persistent complete response
por: Baettig, Florence, et al.
Publicado: (2019)

Detection of isoforms and genomic alterations by high-throughput full-length single-cell RNA sequencing in ovarian cancer
por: Dondi, Arthur, et al.
Publicado: (2023)

MyCTC chip: microfluidic-based drug screen with patient-derived tumour cells from liquid biopsies
por: Schwab, Fabienne D., et al.
Publicado: (2022)

Prognostic Impact of ABO Blood Group on the Survival in Patients with Ovarian Cancer
por: Zhou, Juan, et al.
Publicado: (2015)

The ABO Blood Group is an Independent Prognostic Factor in Patients with Ovarian Cancer
por: Song, Qian, et al.
Publicado: (2019)

Recurrence of vulvar carcinoma: A multidisciplinary approach
por: Rei, M., et al.
Publicado: (2019)

L1 Cell Adhesion Molecule Confers Radioresistance to Ovarian Cancer and Defines a New Cancer Stem Cell Population
por: Terraneo, Nastassja, et al.
Publicado: (2020)

Surgical management of a large postoperative vulvar haematoma following vulvar phlebectomy and ovarian vein embolization for vulvar varicose veins: A case report
por: Theodorou, Georgia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_n6pkke822jgoohu2oue1hq1p1p